Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Latest action · Dec 20, 2018 Received in the Senate.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedDec 19, 2018
- Passed HouseDec 20, 2018
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
This bill reauthorizes, revises, and establishes several programs and entities relating to public health emergency preparedness and response; the bill also specifies requirements for certain over-the-counter drugs that are marketed without an approved application, including fees for associated manufacturing facilities and orders.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 449 | On Motion to Suspend the Rules and Pass | Passed367–9 | Dec 20, 2018 |
Cosponsors 5
Members who signed on, in the order they did. All signed on Dec 19, 2018.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Anna G. Eshoo | Original | Dec 19, 2018 |
| R-KY | Brett Guthrie | Original | Dec 19, 2018 |
| D-MI | Debbie Dingell | Original | Dec 19, 2018 |
| D-CO | Diana DeGette | Original | Dec 19, 2018 |
| R-OH | Robert E. Latta | Original | Dec 19, 2018 |
Committees 4
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Dec 19, 2018 |
| House | Veterans' Affairs Committee | Referred Dec 19, 2018 |
| House | Judiciary Committee | Referred Dec 19, 2018 |
| House | Homeland Security Committee | Referred Dec 19, 2018 |
Actions 10
Everything that happened, newest first.
- Dec 20, 2018Mr. Burgess moved to suspend the rules and pass the bill.
- Dec 20, 2018Considered under suspension of the rules. (consideration: CR H10366-10393)
- Dec 20, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 7328.
- Dec 20, 2018At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- Dec 20, 2018Considered as unfinished business. (consideration: CR H10431)
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H10366–H10393Text printed H10366–H10391Recorded votes H10431enact | Anna G. Eshoo D-CA, Debbie Dingell D-MI, Diana DeGette D-CO, Michael C. Burgess R-TX, Robert E. Latta R-OH, Susan W. Brooks R-IN | Dec 20, 2018 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H10336.
Related bills 8
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 880 | MISSION ZERO Act | Related bill | Feb 27, 2018 |
| S 1022 | MISSION ZERO Act | Related bill | May 3, 2017 |
| S 1834 | Protecting Seniors During Disasters Act | Related bill | Sep 20, 2017 |
| S 2851 | Regional Health Care Emergency Preparedness and Response Systems Act | Related bill | May 15, 2018 |
| S 2852 | Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 | Related bill | Jun 18, 2018 |
Titles 7
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
- Short Titles as Introduced
- Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
- Short Titles as Passed House
- Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
- Short Titles as Introduced for portions of this bill
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
- Over-the-Counter Monograph User Fee Act of 2018
- Short Titles as Passed House for portions of this bill
- Over-the-Counter Monograph User Fee Act of 2018
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Advanced technology and technological innovations
- Advisory bodies
- Aging
- Blood and blood diseases
- Border security and unlawful immigration
- Centers for Disease Control and Prevention (CDC)
- Chemical and biological weapons
- Child health
- Child safety and welfare
- Computer security and identity theft
- Congressional oversight
- Consumer affairs
- Disability and paralysis
- Disaster relief and insurance
- Drug safety, medical device, and laboratory regulation
- Emergency communications systems
- Emergency medical services and trauma care
- Emergency planning and evacuation
- Environmental health
- First responders and emergency personnel
- Food and Drug Administration (FDA)
- General health and health care finance matters
- Genetics
- Government employee pay, benefits, personnel management
- Government information and archives
- Government liability
- Hazardous wastes and toxic substances
- Health
- Health facilities and institutions
- Health information and medical records
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Homeland security
- Hospital care
- Immunology and vaccination
- Infectious and parasitic diseases
- Infrastructure development
- Intelligence activities, surveillance, classified information
- Intergovernmental relations
- Judicial review and appeals
- Licensing and registrations
- Marketing and advertising
- Medical research
- Military medicine
- Minority health
- Musculoskeletal and skin diseases
- Natural disasters
- Performance measurement
- Prescription drugs
- Research and development
- Social work, volunteer service, charitable organizations
- State and local government operations
- Technology assessment
- Terrorism
- User charges and fees
- Veterinary medicine and animal diseases
- Women's health
- World health
Text 3
Each version as it was printed, newest first.
- Dec 20, 2018Engrossed in House
- Dec 20, 2018Received in Senate
- Dec 19, 2018Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.